Danika L. Lew

4.3k citations
72 papers · 2.8k indexed · 1 hit paper · h-index 27
Topics
Cancer Treatment and Pharmacology (26 papers)Breast Cancer Treatment Studies (18 papers)HER2/EGFR in Cancer Research (14 papers)

In The Last Decade

Danika L. Lew

70 papers receiving 2.7k citations

Hit Papers

Circulating Tumor Cells and Response to Chemotherapy in M...20142026201820222014100200300400

Peers

Danika L. Lew
Comparison fields: 5 of 112
  • Oncology 1.8k
  • Cancer Research 1.1k
  • Pulmonary and Respiratory Medicine 697
  • Molecular Biology 408
  • Genetics 355
Replace Nancy A. Dawson with:
Nancy A. Dawson United States
Shigemitsu Takashima Japan
Banu Arun United States
Gamini S. Soori United States
Neelima Denduluri United States
Peter Canney United Kingdom
Eduardo R. Pajon United States
Monica Fornier United States
Kelly Pendergrass United States
Katsumasa Kuroi Japan
Danika L. Lew relative to Nancy A. Dawson United States Nancy A. Dawson's profile →
Citations per field
00.5×1.5×2.3×
Nancy A. Dawson · 1×
Citations per year

Countries citing papers authored by Danika L. Lew

Since Specialization
Citations

This map shows the geographic impact of Danika L. Lew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danika L. Lew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danika L. Lew more than expected).

Fields of papers citing papers by Danika L. Lew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danika L. Lew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danika L. Lew. The network helps show where Danika L. Lew may publish in the future.

Co-authorship network of co-authors of Danika L. Lew

This figure shows the co-authorship network connecting the top 25 collaborators of Danika L. Lew. A scholar is included among the top collaborators of Danika L. Lew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danika L. Lew. Danika L. Lew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 16
3 78
4 70
5 62
6
Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor (HR) positive and HER2-negative breast cancer (BC): SWOG/NRG/Alliance S1207 (NCT01674140).
7
7 7
8 9
9 145
10 0
11 8
12 278
13 4
14 12
15 2
16 31
17 2
18 39
19 6
20 3

About Danika L. Lew

Danika L. Lew is a scholar working on Oncology, Cancer Research and Hematology, having authored 72 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (26 papers), Breast Cancer Treatment Studies (18 papers) and HER2/EGFR in Cancer Research (14 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.8k citations) and Complementary and alternative medicine (177 citations). Danika L. Lew has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Julie R. Gralow, Robert B. Livingston, Gabriel N. Hortobágyi, William E. Barlow, Daniel F. Hayes, Kathy S. Albain, Shaker R. Dakhil, Anne F. Schott, Joseph M. Unger and Dawn L. Hershman. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026